United States · Bill · HR
H.R. 7640 (117th)
To amend the Orphan Drug Act to reauthorize a program of grants and contracts for the development of drugs for rare diseases and conditions (commonly referred to as "orphan drugs").
Introduced
3 May 2022
Last action
3 May 2022 · Introduced
Status
Referred to the House Committee on Energy and Commerce.
Sponsors
Rep. Bilirakis, Gus M. [R-FL-12], Rep. Butterfield, G. K. [D-NC-1]
Subjects
Healthcare
Source updated
7 April 2025
Summary
This bill reauthorizes through FY2027 the Food and Drug Administration's Orphan Products Grants Program, which supports clinical research and product development for rare diseases and conditions.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
3 May 2022
Introduced
Referred to the House Committee on Energy and Commerce.
Source: IntroReferral
3 May 2022
Introduced
Introduced in House
Source: IntroReferral
3 May 2022
Introduced
Introduced in House
Source: IntroReferral
Votes
No vote records are attached yet.
Versions
- Introduced in House · 3 May 2022 · Download file
Documents
3 official files
Introduced in House (text)
This file cannot be previewed here. Use View or Download.
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House (text)
Introduced in House · EN · 3 May 2022
Introduced in House (PDF)
Introduced in House · EN · 3 May 2022
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House
summary · EN · 3 May 2022
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Sponsors
- Rep. Bilirakis, Gus M. [R-FL-12] · R · Sponsor
- Rep. Butterfield, G. K. [D-NC-1] · D · Sponsor
- · hsif00 · Standing
Related records
- related to ← FDASLA Act of 2022
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/117th-congress/house-bill/7640
- Open data entity: https://api.congress.gov/v3/bill/117/hr/7640
- us · 117-hr-7640 · source updated 7 April 2025